Atika Capital Management’s Acceleron Pharma Inc. XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-91,800
| Closed | -$15.8M | – | 133 |
|
|
2021
Q3 | $15.8M | Buy |
91,800
+1,700
| +2% | +$293K | 0.94% | 34 |
|
|
2021
Q2 | $11.3M | Hold |
90,100
| – | – | 0.89% | 44 |
|
|
2021
Q1 | $12.2M | Sell |
90,100
-7,100
| -7% | -$963K | 1.06% | 40 |
|
|
2020
Q4 | $12.4M | Buy |
97,200
+14,200
| +17% | +$1.82M | 0.97% | 40 |
|
|
2020
Q3 | $9.34M | Buy |
83,000
+18,000
| +28% | +$2.03M | 0.76% | 42 |
|
|
2020
Q2 | $6.19M | Buy |
+65,000
| New | +$6.19M | 0.8% | 49 |
|
|
2016
Q3 | – | Sell |
-24,000
| Closed | -$816K | – | 79 |
|
|
2016
Q2 | $816K | Buy |
+24,000
| New | +$816K | 0.35% | 51 |
|